Literature DB >> 3069644

Interaction of blood platelets with the vessel wall.

P F Nievelstein1, P G de Groot.   

Abstract

This review summarizes current insights in the importance of endothelium in the interaction of platelets with the subendothelium. A greater part of the results described are obtained with the use of cultured vessel wall cells. The following subjects are discussed: (1) the pro- and antithrombotic properties of the endothelial cells; (2) the synthesis of subendothelium by the endothelial cells and the influence of the composition of the subendothelium on its reactivity towards blood platelets; (3) the effect of (purified) matrix and plasma proteins on the adhesion process, and (4) various abnormalities of platelet adhesion are discussed that lead to enhanced bleeding tendency or to increased thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069644     DOI: 10.1159/000215816

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  4 in total

1.  Cell type-specific aspects in biocompatibility testing: the intercellular contact in vitro as an indicator for endothelial cell compatibility.

Authors:  Kirsten Peters; Ronald E Unger; Susanne Stumpf; Julia Schäfer; Roman Tsaryk; Bettina Hoffmann; Eva Eisenbarth; Jürgen Breme; Günter Ziegler; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

2.  p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation.

Authors:  J Papkoff; R H Chen; J Blenis; J Forsman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

3.  Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.

Authors:  I S Watts; K A Wharton; B P White; P Lumley
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 4.  Intravenous hemostats: challenges in translation to patients.

Authors:  Margaret Lashof-Sullivan; Andrew Shoffstall; Erin Lavik
Journal:  Nanoscale       Date:  2013-10-02       Impact factor: 7.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.